Steve Jobs' Liver Transplant Confirmed

Methodist University Hospital Transplant Institute in Memphis Says Jobs Has an 'Excellent Prognosis'

Medically Reviewed by Louise Chang, MD on June 24, 2009

June 24, 2009 -- Methodist University Hospital Transplant Institute in Memphis has confirmed that Steve Jobs, Apple's chief executive officer, got a liver transplant there recently.

With Jobs' permission, James D. Eason, MD, program director at Methodist University Hospital Transplant Institute and chief of transplantation, confirmed in a news release that Jobs' liver transplant was done at Methodist University Hospital Transplant Institute in partnership with the University of Tennessee at Memphis.

"Mr. Jobs is now recovering well and has an excellent prognosis," states a news release from Methodist Healthcare, which includes the Methodist University Hospital Transplant Institute.

Media reports of Jobs' liver transplant surfaced last weekend, citing unnamed sources, and now those reports have been confirmed on the record.

Methodist Healthcare notes that Jobs followed all protocols for evaluation and the liver transplant wait list. In the U.S., the wait list for liver transplants is based on how sick a patient is, not how long he or she has been on the wait list.

Jobs was "the sickest patient on the waiting list at the time a donor organ became available," states Methodist Healthcare, which provided no other details about Jobs' case, out of respect for his privacy.

Jobs has previously acknowledged having surgery in 2004 to remove a rare type of pancreatic cancer called an islet cell neuroendocrine tumor.

Methodist Healthcare did not say when Jobs had his liver transplant. Jobs has been on medical leave from Apple since mid-January. An Apple spokeswoman recently told The Wall Street Journal that Jobs still plans to return to work at the end of June.